POCINasdaqElectromedical & Electrotherapeutic ApparatusUS GAAP · USD

Precision Optics Corporation, Inc

Precision Optics Corporation is a U.S.-based developer and manufacturer of advanced optical instruments and micro-optics for medical devices and defense/aerospace applications. Its operations combine custom optical design, engineering services, systems manufacturing, and optical components and assemblies through its POC, Ross Optical, and Lighthouse Imaging businesses.

Kysy yhtiöstä
Liikevaihto31,5milj. USD
+65,2 %v/v
Liikevoitto (EBIT)−3,5milj. USD
+36,8 %v/v
EBIT-marginaali−11,1%
+18,0 %-yks.v/v
Nettotulos−3,6milj. USD
+37,2 %v/v
Vapaa kassavirta−2,0milj. USD
+47,6 %v/v

Tilikausi 2026 · muutos edellisvuodesta

Kehitys 2021–2026

−10010203040milj. USD2021: 11 milj. USD2021: EBIT −0,91 milj. USD20212022: 16 milj. USD2022: EBIT −1,5 milj. USD20222023: 21 milj. USD2023: EBIT −0,64 milj. USD20232024: 19 milj. USD2024: EBIT −2,7 milj. USD20242025: 19 milj. USD2025: EBIT −5,6 milj. USD20252026: 32 milj. USD2026: EBIT −3,5 milj. USD202632−3,5
LiikevaihtoLiikevoitto (EBIT)
Kysy Clarifolta: Precision Optics Corporation, Inc

Liiketoiminta

Osuus liikevaihdosta
Engineering Design Services26 %

Custom optical and medical device design, prototyping, and process development for customer programs.

Systems Manufacturing43 %

Manufacture and assembly of complex optical systems and subassemblies for medical and aerospace customers.

Ross Optical Components and Assemblies20 %

Sourcing, inspection, processing, and resale of custom and catalog optical components.

MicroOptics Lab11 %

Micro-precision optics, lenses, and small-format imaging components for specialized applications.

Tuotteet

Raportoitu · osuus liikevaihdosta
71,8%15,6%11,0%FY2026100 %
  • Systems Manufacturing71,8 %
  • Ross Optical Industries15,6 %
  • Engineering Design Services11,0 %
  • Micro Optics Lab1,6 %

Lähde: 10-K FY2026, yhtiön tuotelinjoittain raportoima liikevaihto (SEC XBRL). Osuudet on laskettu näytetyistä riveistä ja ne summautuvat 100 %:iin.

Asiakkaat

The company sells primarily to medical device companies that outsource optical engineering and manufacturing for minimally invasive surgical products. It also serves defense and aerospace customers that need compact, high-precision optical systems, plus industrial buyers through Ross Optical. Many customers use Precision Optics as a development and manufacturing partner rather than a branded end-product supplier.

Medical device OEMs

Buy endoscopes, imaging systems, and optical subassemblies for minimally invasive surgery programs.

Defense and aerospace contractors

Buy compact optical assemblies and micro-optics for mission-critical systems and communications.

Industrial and specialty optics customers

Buy custom or catalog optical components through Ross Optical for specialized applications.

Emerging medical technology companies

Buy engineering support and early-stage product development services to bring new devices to market.

Strategia

The company is focused on moving customer programs from engineering into manufacturing, where its optical design and production capabilities can be leveraged at scale. It is also building depth in systems manufacturing, micro-optics, and end-to-end medical visualization through Lighthouse Imaging, while maintaining Ross Optical as a sourcing and resale channel. The strategic logic is to win complex outsourced programs, then expand revenue as designs transition into production.

Move programs from engineering into manufacturingKeskipitkä aikaväli

Production work better monetizes completed designs and uses existing manufacturing capabilities.

Expand end-to-end visualization capabilitiesKeskipitkä aikaväli

Integrated engineering and manufacturing can attract customers seeking single-source development.

Increase throughput and yield in manufacturingLyhyt aikaväli

Higher execution quality supports larger customer programs and more reliable delivery.

Broaden customer pipelineLyhyt aikaväli

A wider pipeline reduces dependence on any one program and supports future transitions to production.

Maantiede

The company is headquartered in the United States and markets primarily to U.S.-based medical device customers, while also serving defense and aerospace programs. Its supply chain is global, with specialized optical components sourced from domestic and overseas suppliers, including exposure to tariff-sensitive imports. Manufacturing and engineering operations are centered in the U.S., including assets in Maine and Texas.

Riskit

The business depends on a limited number of customer programs, so revenue can swing when projects end, delay, or move between development and production. It also faces supply-chain, tariff, regulatory, and cybersecurity risks because its products rely on specialized components, controlled defense-related activity, and sensitive customer data.

Järjestetty vakavuuden mukaan
MatalaKohtalainenKorkeaMatalaKohtalainenKorkeaVaikutus →Todennäköisyys →Customer concentration and program timing1Tariffs and trade restrictions2ITAR and export-control compliance3Competitive pressure4Cybersecurity and data protection5
Vaikutus on riskin vakavuus ja todennäköisyys sen toteutumisen todennäköisyys lähivuosina, molemmat arvioitu yhtiön raporttien perusteella. Numerot vastaavat listaa.
  1. Customer concentration and program timingVaikutus: KorkeaTodennäköisyys: Korkea

    Revenue depends on a small number of development and manufacturing programs that can end or delay unexpectedly.

    Kohdistuu: Engineering and systems manufacturing

  2. Tariffs and trade restrictionsVaikutus: KorkeaTodennäköisyys: Kohtalainen

    The company sources specialized optical components globally, so tariffs can raise costs and disrupt supply.

    Kohdistuu: Ross Optical and custom manufacturing supply chain

  3. ITAR and export-control complianceVaikutus: KorkeaTodennäköisyys: Matala

    Defense-related optical products are subject to U.S. regulatory oversight and registration requirements.

    Kohdistuu: Ross Optical and defense/aerospace business

  4. Competitive pressureVaikutus: KeskitasoTodennäköisyys: Korkea

    Larger competitors may have greater capital, manufacturing scale, and sales resources.

    Kohdistuu: Medical device and defense/aerospace markets

  5. Cybersecurity and data protectionVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    The company handles proprietary designs and customer information, making breaches operationally and reputationally damaging.

    KohdistuuEngineeringProduct developmentCustomer data
Kysy Clarifolta: Precision Optics Corporation, Inc

Kirjanpito

Harkinnanvaraiset erät
Revenue recognition across service and manufacturing contracts

Engineering, systems manufacturing, and resale activities may recognize revenue at different points in time, affecting comparability.

Vaikutus: Quarterly mix can shift reported revenue and margins

Allowance for credit losses

Management explicitly identifies this as a critical estimate, affecting receivables valuation.

Vaikutus: Bad-debt provisions can change reported earnings

Inventory and component valuation

Custom optical builds and specialized parts can become obsolete or slow-moving.

Vaikutus: Write-downs can affect gross profit

Impairment of acquired assets and intangibles

Acquired businesses and related intangible assets require ongoing recoverability assessment.

Vaikutus: Potential non-cash charges if expected cash flows weaken

Samankaltaisia listattuja yhtiöitä

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

Syntec Optics Holdings, Inc

OPTXW · Optical Instruments & Lenses

TechPrecision Corporation

TPCS · Fabricated Structural Metal Products

Optex Systems Holdings Inc

OPXS · Optical Instruments & Lenses

IPG Photonics Corporation

IPGP · Semiconductors & Related Devices

The Eastern Company

EML · Cutlery, Handtools & General Hardware

Moog Inc.

MOG-A · Misc Industrial & Commercial Machinery & Equipment

Päivitetty: 24.9.2026

Precision Optics Corporation, Inc (POCI) liikevaihto, tulos ja tunnusluvut 2026 – Clarifo